Perspectives On Optimizing Chronic Heart Failure Care Beyond Randomised Controlled Trials – What do we Consolidate and how do we Plan for the Future?

Author(s): Pupalan Iyngkaran*, Merlin Thomas, Sandawana W. Majoni.

Journal Name: Current Cardiology Reviews

Volume 15 , Issue 3 , 2019

Become EABM
Become Reviewer

[1]
Iyngkaran P. Editorial: Optimizing chronic heart failure care beyond randomised controlled trials - What are the problem areas and potential solutions? Curr Cardiol Rev 2016; 12(3): 164-5.
[2]
NHFA CSANZ Heart Failure Guidelines Working Group. Atherton JJ, Sindone A, et al National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, detection, and management of heart failure in Australia 2018. Heart Lung Circ 2018; 27(10): 1123-208.
[3]
Krumholz HM, Currie PM, Riegel B, et al. American Heart Association Disease Management Taxonomy Writing Group. A taxonomy for disease management: A scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation 2006; 14(13): 1432-45.
[4]
Iyngkaran P, Liew D, Neil C, Driscoll A, Marwick TH, Hare DL. Moving from heart failure guidelines to clinical practice: Gaps contributing to readmissions in patients with multiple comorbidities and older age. Clin Med Insights Cardiol 2018; 12: 1179546818809358.
[5]
Fitzgerald AA, Allen LA, Masoudi FA. The evolving landscape of quality measurement for heart failure. Ann N Y Acad Sci 2012; 1254: 131-9.
[6]
Iyngkaran P, Liew D, McDonald P, et al. Phase 4 studies in heart failure - what is done and what is needed? Curr Cardiol Rev 2016; 12(3): 216-30.
[7]
Iyngkaran P, Majoni W, Cass A, et al. Northern Territory perspectives on heart failure with comorbidities – understanding trial validity and exploring collaborative opportunities to broaden the evidence base. Heart Lung Circ 2015; 24(6): 536-43.
[8]
Thomas MC. Type 2 diabetes and heart failure: Challenges and solutions. Curr Cardiol Rev 2016; 12(3): 249-55.
[9]
Iyngkaran P, Thomas M, Majoni W, Anavekar NS, Ronco C. Comorbid heart failure and renal impairment: Epidemiology and management. Cardiorenal Med 2012; 2(4): 281-97.
[10]
Shakib S, Clark RA. Heart failure pharmacotherapy and supports in the elderly - A short review. Curr Cardiol Rev 2016; 12(3): 180-5.
[11]
Iyngkaran P, Thomas M. Bedside-to-bench translational research for chronic heart failure: Creating an agenda for clients who do not meet trial enrollment criteria. Clin Med Insights Cardiol 2015; 9(Suppl. 1): 121-32.
[12]
Iyngkaran P, Toukhsati SR, Biddagardi N, Zimmet H, Atherton J, Hare DL. Technology-assisted congestive heart failure care. Curr Heart Fail Rep 2015; 12(2): 173-86.
[13]
Thomas MC. Perspective review: Type 2 diabetes and readmission for heart failure. Clin Med Insights Cardiol 2018; 12: 1179546818779588.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 15
ISSUE: 3
Year: 2019
Page: [158 - 160]
Pages: 3
DOI: 10.2174/1573403X1503190506101720

Article Metrics

PDF: 40
HTML: 3